Loading...
  • human umbilical
  • ENDV ) ("Endonovo" or the "Company"), an innovative biotechnology company developing bioelectronics-based products and therapies for regenerative medicine, announced that it is developing a next-generation, off-the-shelf treatment for Graft-Versus-Host Disease (GVHD) using Cytotronicsâ„¢ expanded and ex vivo enhanced stem cells from the human umbilical cord. (marketwired.com)
  • We have taken our method of expanding a population of immune privileged stem cells from the human umbilical cord and combined it with our Cytotronics platform to create large quantities of optimized immuno-regulatory stem cells that can be used as an allogeneic, off-the-shelf therapy for the treatment of Graft-Versus-Host Disease," commented Endonovo Chief Scientist, Dr. Donnie Rudd. (marketwired.com)
  • Endonovo previously announced a method and composition process for the creation of a cell mixture from a portion of the human umbilical cord co-cultured with adipose-derived stem cells. (marketwired.com)
  • Myeloablative
  • More recently non-myeloablative, "mini transplant( microtransplantation )," procedures have been developed that require smaller doses of preparative chemo and radiation. (wikipedia.org)
  • Cancer
  • Cediranib maleate may stop the growth of ovarian, fallopian tube, or primary peritoneal cancer by blocking the growth of new blood vessels necessary for tumor growth. (clinicaltrials.gov)
  • Pediatric Blood and Cancer. (northwestern.edu)
  • Colorado Blood Cancer Institute (CBCI) is a new program established by the expert physicians who have served Rocky Mountain Blood and Marrow Transplant Program patients for more than 15 years. (dana-farber.org)
  • Referral to a blood cancer specialist early after diagnosis allows for full evaluation of treatment options and the development of a treatment plan including access to approximately 50 clinical trials. (dana-farber.org)
  • A multidisciplinary team, including nurse navigators, provides personalized care in the 49-bed inpatient unit and outpatient Cancer and Therapeutic Blood Treatment Center. (dana-farber.org)
  • The NYOH medical staff includes 35 board certified physicians who specialize in the care of patients with cancer (medical oncology and radiation oncology) and blood-related disorders (hematology). (dana-farber.org)
  • If you require a matching donor for BMT, your transplant team at The University of Kansas Cancer Center will find a donor for you. (kucancercenter.org)